Educational Program to Prevent Iodine Deficiency in Young Women Aged 18 to 24 in Europe and South Asia
Led by EUthyroid · Updated on 2025-02-05
1000
Participants Needed
6
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating educational interventions to raise awareness about iodine deficiency risks among young women aged 18 to 24 in three European countries Norway, Poland, UK, as well as Bangladesh and Pakistan. Iodine deficiency is a leading cause of thyroid disorders and can contribute to developmental problems in children when pregnant women are affected. This cluster-randomized controlled trial aims to reduce iodine deficiency and related health burdens in adolescents and young women by implementing tailored educational measures in ambulatory care settings.
The study will include 10 clusters per country, split evenly between intervention and control groups, with a total of 200 participants per country. The intervention consists of four components an iodine feedback tool, an educational conversation with a trained healthcare professional, an iodine factsheet, and an iodine video. Healthcare professionals delivering the intervention will receive specialized training before participant recruitment. Measurements will occur at baseline before the intervention, then at 2-4 weeks and again at 6-8 months post-intervention to assess changes over time.
Participants will complete questionnaires to measure iodine awareness and knowledge, dietary intake, and urinary iodine levels at each time point. Sociodemographic and dietary habits will also be recorded. Healthcare professionals and participants will be surveyed, and some will take part in interviews for a process evaluation. The study will monitor changes in iodine-related behaviors and knowledge while comparing intervention and control groups to evaluate the effectiveness of the educational measures over approximately eight months.
CONDITIONS
Brief Title
EUthyroid2: the Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe
Research Team
H
Henry Völzke
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Sufficient language skills to understand study information, informed consent, and the questionnaire
You will not qualify if you...
Having a thyroid disease
Pregnancy at the time of recruitment and during the intervention period
Lactation
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - Single intervention session
Participants receive an educational intervention about iodine, iodine deficiency, dietary iodine sources, and iodine during pregnancy, delivered through multiple components including a feedback tool, conversation with a healthcare professional, factsheet, and video.
1 visit (in-person) for the educational intervention
Outpatient Treatment
Duration - 6 to 8 months
Participants complete two follow-up measurements to assess awareness, iodine status, dietary intake, and behaviors related to iodine.
2 visits (first follow-up at 2-4 weeks and second follow-up at 6-8 months after the intervention)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Educational Program to Prevent Iodine Deficiency in Young Women Aged 18 to 24 in Europe and South Asia
Educational Program to Increase Awareness and Prevent Iodine Deficiency and Related Disorders in Adolescents Across Europe
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Enhancing iodine health awareness among adolescents: a study protocol for a multi-country intervention study in educational settings across the UK, Slovenia, Cyprus, Bangladesh, Germany and Pakistan.
Bodil Just Christensen, Natalia Cecon-Stabel, Synnøve Naess Sleire...